Proton Pump Inhibitors Accelerate Endothelial Senescence.
Where this comes from
- Record sourced from PubMed, PMID 27166251.
- Also identified by DOI 10.1161/CIRCRESAHA.116.308807 and PMC identifier 4902745.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Proton pump inhibitors (PPIs) are popular drugs for gastroesophageal reflux, which are now available for long-term use without medical supervision. Recent reports suggest that PPI use is associated with cardiovascular, renal, and neurological morbidity. To study the long-term effect of PPIs on endothelial dysfunction and senescence and investigate the mechanism involved in PPI-induced vascular dysfunction. Chronic exposure to PPIs impaired endothelial function and accelerated human endothelial senescence by reducing telomere length. Our data may provide a unifying mechanism for the association of PPI use with increased risk of cardiovascular, renal, and neurological morbidity and mortality.
Medical subject headings
- Cellular Senescence
- Endothelial Cells
- Proton Pump Inhibitors